-+ 0.00%
-+ 0.00%
-+ 0.00%
Santoku Technology said on an interactive platform on November 11 that its subsidiary Sante Yingtai has sales orders in the field of semiconductor material testing, but this business accounts for a relatively low share of the company's revenue. In 2025, the subsidiary's revenue was only 3.32% of that of the listed company. The company will continue to pay attention to technology trends in various industries and carefully evaluate related business expansion opportunities. Currently, there are no plans for shareholding, mergers and acquisitions, or joint R&D.
Share
Listen to the news
Santoku Technology said on an interactive platform on November 11 that its subsidiary Sante Yingtai has sales orders in the field of semiconductor material testing, but this business accounts for a relatively low share of the company's revenue. In 2025, the subsidiary's revenue was only 3.32% of that of the listed company. The company will continue to pay attention to technology trends in various industries and carefully evaluate related business expansion opportunities. Currently, there are no plans for shareholding, mergers and acquisitions, or joint R&D.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending